Hybrid manganese dioxide-bovine serum albumin nanostructure incorporated with doxorubicin and IR780 for enhanced breast cancer chemo-photothermal therapy

References

• Abbas M, Zou Q, Li S, Yan X. (2017). Self-assembled peptide- and protein-based nanomaterials for antitumor photodynamic and photothermal therapy. Adv Mater 29:1605021.
   Web of Science ®Google Scholar
• Cai X, Gao W, Ma M, et al. (2015). A prussian blue-based core–shell hollow-structured mesoporous nanoparticle as a smart theranostic agent with ultrahigh pH-responsive longitudinal relaxivity. Adv Mater 27:6382–9.
   PubMed Web of Science ®Google Scholar
• Carnero A, Lleonart M. (2016). The hypoxic microenvironment: a determinant of cancer stem cell evolution. BioEssays 38:S65–S74.
   PubMed Web of Science ®Google Scholar
• Chen Q, Feng L, Liu J, et al. (2016). Intelligent albumin–MnO2 nanoparticles as pH-/H2O2-responsive dissociable manocarriers to modulate tumor hypoxia for effective combination therapy. Adv Mater 28:7129–36.
   PubMed Web of Science ®Google Scholar
• Dagogo-Jack I, Shaw AT. (2018). Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol 15:81–94.
   PubMed Web of Science ®Google Scholar
• Feng L, Xie R, Wang C, et al. (2018). Magnetic targeting, tumor microenvironment-responsive intelligent nanocatalysts for enhanced tumor ablation. ACS Nano 12:11000–12.
   PubMed Web of Science ®Google Scholar
• Gai S, Yang G, Yang P, et al. (2018). Recent advances in functional nanomaterials for light–triggered cancer therapy. Nano Today 19:146–87.
   Web of Science ®Google Scholar
• Gatenby RA, Gillies RJ. (2004). Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4:891–9.
   PubMed Web of Science ®Google Scholar
• Harris AL. (2002). Hypoxia — a key regulatory factor in tumour growth. Nat Rev Cancer 2:38–47.
   PubMed Web of Science ®Google Scholar
• Hu C, Cun X, Ruan S, et al. (2018). Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy. Biomaterials 168:64–75.
   PubMed Web of Science ®Google Scholar
• Huang X, Yin Y, Wu M, et al. (2019). LyP-1 peptide-functionalized gold nanoprisms for SERRS imaging and tumor growth suppressing by PTT induced-hyperthermia. Chinese Chem Lett 30:1335–40.
   Web of Science ®Google Scholar
• Kemp JA, Shim MS, Heo CY, Kwon YJ. (2016). “Combo” nanomedicine: co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy. Adv Drug Deliver Rev 98:3–18.
   PubMed Web of Science ®Google Scholar
• Li F, Mei H, Gao Y, et al. (2017). Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer. Biomaterials 145:56–71.
   PubMed Web of Science ®Google Scholar
• Lin L-S, Song J, Song L, et al. (2018). Simultaneous fenton-like ion delivery and glutathione depletion by MnO2-based nanoagent to enhance chemodynamic therapy. Angew Chem Int Ed 57:4902–6.
   PubMed Web of Science ®Google Scholar
• Liu J, Chen Q, Feng L, Liu Z. (2018a). Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement. Nano Today 21:55–73.
   Web of Science ®Google Scholar
• Liu R, Hu C, Yang Y, et al. (2019). Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment. Acta Pharm Sin B 9:410–20.
   PubMed Web of Science ®Google Scholar
• Liu R, Xiao W, Hu C, et al. (2018b). Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis. J Control Release 278:127–39.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Marchesi F, Malesci A, et al. (2017). Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14:399.
   PubMed Web of Science ®Google Scholar
• Martin JD, Fukumura D, Duda DG, et al. (2016). Reengineering the tumor microenvironment to alleviate hypoxia and overcome cancer heterogeneity. Cold Spring Harb Perspect Med 6:a027094.
   PubMed Web of Science ®Google Scholar
• Pan J, Wang Y, Pan H, et al. (2017). Mimicking drug–substrate interaction: a smart bioinspired technology for the fabrication of theranostic nanoprobes. Adv Funct Mater 27:1603440.
   Web of Science ®Google Scholar
• Peng J, Dong M, Ran B, et al. (2017a). “One-for-all”-type, biodegradable prussian blue/manganese dioxide hybrid nanocrystal for trimodal imaging-guided photothermal therapy and oxygen regulation of breast cancer. ACS Appl Mater Interfaces 9:13875–86.
   PubMed Web of Science ®Google Scholar
• Peng J, Yang Q, Li W, et al. (2017b). Erythrocyte-membrane-coated prussian blue/manganese dioxide nanoparticles as H2O2-responsive oxygen generators to enhance cancer chemotherapy/photothermal therapy. ACS Appl Mater Interfaces 9:44410–22.
   PubMed Web of Science ®Google Scholar
• Peng J, Yang Q, Shi K, et al. (2019a). Intratumoral fate of functional nanoparticles in response to microenvironment factor: Implications on cancer diagnosis and therapy. Adv Drug Deliv Rev 143:37–67.
   PubMed Web of Science ®Google Scholar
• Peng J, Yang Q, Xiao Y, et al. (2019b). Tumor microenvironment responsive drug-dye-peptide nanoassembly for enhanced tumor-targeting, penetration, and photo-chemo-immunotherapy. Adv Funct Mater 29:1900004.
   Web of Science ®Google Scholar
• Pernicova I, Korbonits M. (2014). Metformin—mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol 10:143–56.
   PubMed Web of Science ®Google Scholar
• Prasad P, Gordijo CR, Abbasi AZ, et al. (2014). Multifunctional albumin–MnO2 nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response. ACS Nano 8:3202–12.
   PubMed Web of Science ®Google Scholar
• Rey S, Schito L, Wouters BG, et al. (2017). Targeting hypoxia-inducible factors for antiangiogenic cancer therapy. Trends Cancer 3:529–41.
   PubMed Web of Science ®Google Scholar
• Robertson-Tessi M, Gillies RJ, Gatenby RA, Anderson ARA. (2015). Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes. Cancer Res 75:1567–79.
   PubMed Web of Science ®Google Scholar
• Song M, Liu T, Shi C, et al. (2016). Bioconjugated manganese dioxide nanoparticles enhance chemotherapy response by priming tumor-associated macrophages toward M1-like phenotype and attenuating tumor hypoxia. ACS Nano 10:633–47.
   PubMed Web of Science ®Google Scholar
• Wu W, Yang Q, Li T, et al. (2009). Hemoglobin-based oxygen carriers combined with anticancer drugs may enhance sensitivity of radiotherapy and chemotherapy to solid tumors. Artif Cell Nanomed. B 37:163–5.
   Web of Science ®Google Scholar
• Xiao, W, Xiong, J, Zhang, S, et al. (2018). Influence of ligands property and particle size of gold nanoparticles on the protein adsorption and corresponding targeting ability. Inter J Pharmaceut 538:105–11.
   PubMed Web of Science ®Google Scholar
• Xu J, Han W, Yang P, et al. (2018). Tumor Microenvironment‐Responsive Mesoporous MnO2‐Coated Upconversion Nanoplatform for Self‐Enhanced Tumor Theranostics. Adv Funct Mater 28:1803804.
   Web of Science ®Google Scholar
• Yang Q, Peng J, Shi K, et al. (2019a). Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy. J Control Release 308:29–43.
   PubMed Web of Science ®Google Scholar
• Yang Q, Peng J, Xiao Y, et al. (2018). Porous Au@Pt nanoparticles: therapeutic platform for tumor chemo-photothermal co-therapy and alleviating doxorubicin-Induced oxidative damage. ACS Appl Mater Interfaces 10:150–64.
   PubMed Web of Science ®Google Scholar
• Yang Q, Xiao Y, Yin Y, et al. (2019b). Erythrocyte membrane-camouflaged IR780 and DTX coloading polymeric nanoparticles for imaging-guided cancer photo–chemo combination therapy. Mol Pharmaceutics 16:3208–20.
   PubMed Web of Science ®Google Scholar
• Zhou J, Xue C, Hou Y, et al. (2019). Oxygenated theranostic nanoplatforms with intracellular agglomeration behavior for improving the treatment efficacy of hypoxic tumors. Biomaterials 197:129–45.
   PubMed Web of Science ®Google Scholar
• Zhou L, Wu Y, Meng X, et al. (2018). Dye-anchored MnO nanoparticles targeting tumor and inducing enhanced phototherapy effect via mitochondria-mediated pathway. Small 14:1801008.
   Web of Science ®Google Scholar
• Zhu P, Chen Y, Shi J. (2018). Nanoenzyme-augmented cancer sonodynamic therapy by catalytic tumor oxygenation. ACS Nano 12:3780–95.
   PubMed Web of Science ®Google Scholar
• Zuccala E. (2016). Clocking up resistance. Nat Rev Cancer 16:343.
   PubMed Web of Science ®Google Scholar